Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - NovaBay Pharmaceuticals, Inc. | novabay_10k-123109.htm |
| EX-31.1 - EXHIBIT 31.1 - NovaBay Pharmaceuticals, Inc. | ex31-1.htm |
| EX-10.7 - EXHIBIT 10.7 - NovaBay Pharmaceuticals, Inc. | ex10-7.htm |
| EX-32.1 - EXHIBIT 32.1 - NovaBay Pharmaceuticals, Inc. | ex32-1.htm |
| EX-32.2 - EXHIBIT 32.2 - NovaBay Pharmaceuticals, Inc. | ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - NovaBay Pharmaceuticals, Inc. | ex31-2.htm |
| EX-10.20 - EXHIBIT 10.20 - NovaBay Pharmaceuticals, Inc. | ex10-20.htm |
| EX-10.14 - EXHIBIT 10.14 - NovaBay Pharmaceuticals, Inc. | ex10-14.htm |
| EX-10.22 - EXHIBIT 10.22 - NovaBay Pharmaceuticals, Inc. | ex10-22.htm |
| EX-10.19 - EXHIBIT 10.19 - NovaBay Pharmaceuticals, Inc. | ex10-19.htm |
| EX-10.18 - EXHIBIT 10.18 - NovaBay Pharmaceuticals, Inc. | ex10-18.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statements No. 333-147334, 333-157041 and 333-164469, on Form S-8, and in Registration Statement No. 333-159917, on Form S-3, of our report dated March 26, 2010, with respect to the consolidated financial statements of NovaBay Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2009.
/s/ Davidson & Company LLP
“DAVIDSON & COMPANY LLP”
|
Vancouver, Canada
|
Chartered Accountants
|